BAH
- NYSE - Comml Svcs-Consulting
Booz Allen Hamilton Cl A
|
$90.12 |
-2.72 -2.93%
|
$92.05
|
$93.45
|
-3.56% |
567,384 52.78%
|
1,075,000
|
Most Recent Note for BAH - 7/5/2022 12:10:17 PM
Reported earnings -3% on +13% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly earnings increases were below the +25% minimum earnings guideline (C criteria) with sub par sales revenues growth. This Commercial Services - Consulting firm's annual earnings history (A criteria) has been steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BWXT
- NYSE - Electrical-Power/Equipmt
B W X Technologies Inc
|
$53.98 |
-2.46 -4.36%
|
$56.13
|
$62.53
|
-13.67% |
292,238 51.54%
|
567,000
|
Most Recent Note for BWXT - 7/5/2022 12:10:31 PM
Earnings history has been erratic and not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CCMP
- NASDAQ - CHEMICALS - Specialty Chemicals
Cabot Microelectronics
|
$172.02 |
-0.66 -0.38%
|
$173.41
|
$197.00
|
-12.68% |
243,710 62.65%
|
389,000
|
Most Recent Note for CCMP - 7/5/2022 12:10:58 PM
Consolidating in a tight range since M&A news 12/15/21. Reported earnings +13% on +12% sales revenues Mar '22 quarter versus the year ago period, and prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings history (A criteria) included a downturn in FY '21.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DGII
- NASDAQ - COMPUTER HARDWARE - Networking & Communication Dev
Digi International Inc
|
$23.11 |
-0.62 -2.61%
|
$23.44
|
$26.03
|
-11.22% |
121,675 56.86%
|
214,000
|
Most Recent Note for DGII - 7/5/2022 12:11:36 PM
Stalled after recently touching a new 52-week high. Noted with caution in prior mid-day reports - "Earnings rose +52% on +23% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings history included a downturn in FY '17-18."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GIS
- NYSE - FOOD & BEVERAGE - Food - Major Diversified
General Mills Inc
|
$74.45 |
-1.34 -1.77%
|
$76.09
|
$75.96
|
-1.99% |
2,413,646 62.63%
|
3,854,000
|
Most Recent Note for GIS - 7/5/2022 12:12:15 PM
Perched at its all-time high after volume-driven gains last week. Sub par sales revenues increases and earnings versus year ago quarterly comparisons through May '22 versus the year ago period. Annual earnings growth has been slow and steady for this well-known name in the Food - Packaged industry group. Fundamentals fall short of the C and A criteria of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LMT
- NYSE - AEROSPACE/DEFENSE - Aerospace/Defense - Major
Lockheed Martin Corp
|
$409.92 |
-23.60 -5.44%
|
$425.77
|
$479.99
|
-14.60% |
704,752 54.34%
|
1,297,000
|
Most Recent Note for LMT - 7/5/2022 12:16:10 PM
Pulling back abruptly today after meeting resistance near its 50 DMA line. Noted with caution in the 3/07/22 mid-day report at its all-time high - "Reported earnings +12% on +4% sales revenues for the Dec '21 quarter versus the year ago period, and prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NL
- NYSE - Hsehold/Office Furniture
N L Industries
|
$9.03 |
-0.15 -1.63%
|
$9.19
|
$10.20
|
-11.47% |
40,309 93.74%
|
43,000
|
Most Recent Note for NL - 7/5/2022 12:17:04 PM
Pulling back from its 52-week high hit last week. Found support well above its 50 DMA line ($8.37) after rallying from a sound base pattern in recent weeks. Prior mid-day reports cautioned members - "Earnings and sales revenues history is below the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$109.57 |
-2.07 -1.85%
|
$109.92
|
$122.16
|
-10.31% |
1,278,408 85.28%
|
1,499,000
|
Most Recent Note for NVO - 7/5/2022 12:17:25 PM
This Denmark-based Medical - Ethical Drug firm is consolidating near its 50 and finding support near its 200 DMA line. Prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain after it reported Mar '22 quarterly earnings +8% on +17% sales revenues versus the year ago period."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OTTR
- NASDAQ - UTILITIES - Electric Utilities
Otter Tail Corp
|
$65.16 |
-4.30 -6.19%
|
$70.03
|
$71.89
|
-9.36% |
110,239 67.22%
|
164,000
|
Most Recent Note for OTTR - 7/5/2022 12:18:52 PM
Retreating abruptly today after challenging its 52-week high with a spurt of volume-driven gains. Faces little resistance due to overhead supply up to the $71 level. Recently found support near its 200 DMA line. Quarterly earnings and sales revenues increases in comparisons through Mar '22 have been well above the +25% minimum guideline (C criteria). Annual earnings history has been steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PRDO
- NASDAQ - Consumer Svcs-Education
Perdoceo Education Corp
|
$11.68 |
-0.38 -3.15%
|
$11.99
|
$12.65
|
-7.67% |
315,896 50.79%
|
622,000
|
Most Recent Note for PRDO - 7/5/2022 12:19:56 PM
Fundamental concerns remain due to sub par sales revenues and earnings growth.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
USAK
- NASDAQ - TRANSPORTATION - Trucking
U S A Truck Inc
|
$31.08 |
+0.03
0.10%
|
$31.32
|
$31.67
|
-1.86% |
267,009 109.88%
|
243,000
|
Most Recent Note for USAK - 7/5/2022 12:21:14 PM
Holding its ground after a gap up on 6/24/22 M&A news. Recent quarterly comparisons through Mar '22 were strong but its prior earnings history is not a match with the fundamental guidelines of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VIVO
- NASDAQ - DRUGS - Diagnostic Substances
Meridian Bioscience Inc
|
$31.01 |
+0.11
0.36%
|
$31.46
|
$31.93
|
-2.88% |
284,018 69.10%
|
411,000
|
Most Recent Note for VIVO - 7/5/2022 12:21:45 PM
Holding its ground stubbornly after volume-driven gains helped it recently hit a new 52-week high. Prior mid-day reports cautioned members - "Quarterly earnings increases through Mar '22 versus the year ago periods have been below the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines. On 4/18/08 it was dropped from the Featured Stocks list."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|